There are no discussions yet.

  • Disease Description


    Type 2 diabetes mellitus is a disorder affecting the way your body uses glucose (sugar). Cells in your body need sugar to work normally and sugar gets into the cells with the help of the hormone called insulin. Without enough insulin, or if the body stops responding to insulin, sugar builds up in the blood.[1]


    In type 2 diabetes mellitus, the pancreas does not make enough insulin, the body becomes resistant to normal or even high levels of insulin, or both. This causes high blood glucose (blood sugar) levels, which can cause serious problems if untreated.[1]


    Type 2 diabetes is a medical condition that requires regular monitoring and treatment throughout your life. Fortunately, with proper treatment one can keep blood sugar levels close to normal and minimize the risk of developing complications.[1]


    Prevalence


    In 2012, 29.1 million Americans, or 9.3% of the population, had diabetes. Diabetes remains the 7th leading cause of death in the United States in 2010, with 69,071 death certificates listing it as the underlying cause of death, and a total of 234,051 death certificates listing diabetes as an underlying or contributing cause of death. In the United States, Canada, and Europe, about 90 percent of all people with diabetes have type 2 diabetes.[2]


    Current Treatment Options


    Treatment includes lifestyle changes, self-care measures, and sometimes medications.A number of oral medicines (pills) are available to treat type 2 diabetes. [2]


    Metformin — Most people who are newly diagnosed with type 2 diabetes will immediately begin a medicine called metformin (Glucophage, Glumetza, Riomet, Fortamet). Metformin improves how your body responds to insulin to reduce high blood sugar levels.[2]


    Insulin — In the past, insulin treatment was reserved for patients with type 2 diabetes whose blood sugars were not controlled with oral medicines and lifestyle changes. However, there is increasing evidence that using insulin at earlier stages may improve overall diabetes control and help to preserve the pancreas's ability to make insulin.[2]


    There are a number of additional medications on the market. You should consult with your health care provider to see which medications are right for you.


    Evidence for and Proposed Mechanism for Cannabinoid Therapies


    The study of the role of the endocannabinoids and their receptors in food intake and energy balance led, only little more than a decade after the identification of the endocannabinoid signaling system, to the development of several new therapeutic drugs. However due to unwanted side effects these drugs were eventually removed from the market.[3]


    Rather than global obesity, often associated with depressive disorders, the indication novel cannabinoid compounds, as well as of other strategies aiming at reducing endocannabinoid overactivity, should be instead for those metabolic dysfunctions that are associated with abdominal obesity. For example, the administration of second-generation CB1 receptor antagonists to moderately obese patients is likely to improve considerably the benefit/risk ratio of these compounds and result in long-term beneficial outcomes on type 2 diabetes.[3]


    1) UpToDate online resource


    2) American Diabetes Association


    3) Mechoulam et al. Cannabinoids and Endocannabinoids in Metabolic Disorders with Focus on Diabetes

  • Category
    Critical Ailments
  • Created
    Thursday, 16 March 2017
  • Group admin
    CBIS

American States University

EBYH CSi EDP Drug Partner

*** Warning this document contains graphic images.

Click the above Image to Review our Cancer Drug Comparables

 

1mmCover2.JPG

Click the above Image to Review our 1-Million Strong FC, Media Kit

*** Warning this document contains exciting images. 

    1mmCover_Member1_Size.JPG  

Click the surrounding Images to become one of the First 1-Million Strong Killing Cancers, Fight Club Members to help 'Make that Change' Join in  Now!  *** Warning this Membership contains Exciting Results.

PS ... ALL of our CSi-VIP's, CSi-GIFT Share Recipients (Paid Processing Fees), CSi-Award Recipients, and those who Donated through the GO-Fund-Me Promotion are ALL Automatically included as "1-Million Strong Killing Cancers, Fight Club Members!"

You do not need to purchase anything, you are ALREADY included in the "First" 1-Million Membership Club, CONGRATULATIONS !!!

1mmCover_Member3_Size.JPG1mmCover_Member2_Size.JPG

 Please Click the Calendar image below to book your time to speak with Mr. Dabney about "Your Final CSi-VIP Shareholder Legacy". 

  Calender_Clean_Capture.JPG

 ALL of your PREVIOUS Cannabis Science (CBIS) Shares are on Record with the Company and with the Transfer Agent (As Confirmed by the SEC).

The Company does NOT have your Original trading CBIS Shares, either you have them, or your Brokerage Firm has them (with new identifier codes) or the Transfer Agent has them.

You can confirm with your Broker (Please obtain an Official Brokerage Firm Letter Representing where your CBIS shares are).

Your CBIS GIFT Shares are on Record Books with the Company and/or in your possesion for Regulatory submissions, Registered Legal Opinion Letters, and awaiting Final Audit for Final Trading approvals. 

Your CBIS Shares are legal tender and we are ALL waiting for the FINAL Confirmations for trading once the Audits and Legal Filings are completed. 

*** We will announce the FINAL CBIS acquisition changes and Corporate Mergers once the filings are completed, so as long as you know where your CBIS Shares are, you are GOOD.

As clearly stated by Mr. Dabney "Our History is Building up into our Inaugural Event of our Lifetime, the Inaugural 1-Million Strong Killing Cancers, Fight Club, VIP Fundraiser Event, dubbed, 'Celebrities Raising $20 Million to Keep Killing Cancers' the Initiative is fueled further with the '1- Million Strong Killing Cancers, Variety Television Show' through the ASU 'Make that Change Campaign'. Hence the accumulation of 1-Million people donating $20 each, because we are ALL Celebrities in our own Rights.

This is More than enough Funding to begin our FDA Clinical Trials for our 'Low-Cost Cancer Drugs' to treat millions Worldwide that already has proven HARVARD Award Winning Cancer Killing Success!

AND

This is also PLENTY of Funding to bring ALL our CBIS Shares back trading again and follow through with our Original Complete Cannabis Science Share trading Game Plan, and We Win, once again. Hopefully we'll see you at the Event to help 'Make that Change'!"


Should you have any further questions regarding your CBIS Shares or additional Share Ownership, Please Click the above Calendar Link
to book your time to speak with Mr. Dabney about "Your Final CSi-VIP Shareholder Legacy". 

 

 CSi-Legacy_Drug_Update_SideBar.jpg

Drug Valuation Image3

Harvard GHC Award RCD 2018

 

The ASU Digital Business HUB will be used as the main business student learning center. GBXI will be the main pivot point to spin out trading shares of all our Partner Public and Private Companies such as Cannabis Science, iCannabinoid, Thermic Science, LNC, LMG, and a few more old and new school surprises for our loyal shareholders. No one will be missed! A true Digital Business HUB for students, just as planned all along.

Each spinout company will give our GBXI registered shareholders additional pro-rata shares in each spinout company over and above their original shares in each entity. This provides the required shareholder base for each company required to trade and gives additional shares to all our loyal GBXI shareholders.

We call this “Compounding our Wealth” through extra spinout share participation for all our loyal GBXI shareholders. Each registered GBXI shareholder will receive additional shares of each spinout Company over and above their original shares to enjoy additional liquidity as each company begins to trade through the GBXI Digital Business HUB spinout process.

 

Click here to review the Report:

Frontiers Capture
1mmStrong July 8 Court UPDATE Brochure Image

Sac Court Capture

Case No. 2:17-CV-02271-KJM-JDP



Inspire, Dream, Change

YOUR DIGITAL ERA Personal & Business Access Learning HUB
 


Observational Studies

PART

Activity Stream

George Hogan posted a new discussion1 hour 9 minutes ago

Still sitting on CBIS shares... what gives?

I periodically check in on this site, but it's so poorly organized that it's impossible to find anything other than Mr. Dabney's cheerleading posts....

Investor Relations
George Hogan and 608 others have joined the group Investor Relations 1 hour 19 minutes ago

Cannabis Science Inc. "Shareholder Loyalty Gift Center of Excellence"

HARVARD Award Winning 
CANCER Killing Success





1st HARVARD Award Winning
Stage 4 Lung Cancer Killing Article:
*** Please click image below.

Frontiers_1.JPG


2nd HARVARD Award Winning
Stage 4 Lung Cancer Killing Article:
*** Please click image below.

 Frontiers_2.JPG


*** PLUS

(3) other Cannabis Science
REAL WORLD Successes:

Stage 4 Breast Cancer

WhatsApp_Image_2022-05-21_at_9.37.37_AM_3.jpg
Skin Cancer 

WhatsApp_Image_2022-05-21_at_9.37.38_AM.jpeg
Karposis Sarcoma

WhatsApp_Image_2022-05-21_at_9.37.38_AM_1.jpeg

CSi Final GIFT Share Issuance Nov 27 2022



Cannabis Science CEO, Presents …

The FINAL “CBIS GIFT Shares” Issuances!

DECEMBER 1, 2022, Cheers! & HAPPY HOLIDAYS !!!

ALL GIFT Shares 1, 2, & 3 being ISSUED !!!

 LAST Steps:

Please confirm Yours NOW !!!

1. CONFIRM Correct Total Share Amount(s)

2. CONFIRM Correct Name(s) on CERTIFICATE

3. CONFIRM Correct Mailing Address

ASU/CSi-EDP-ECO-System
At it's FINEST !!! 

WHICH ONE ARE YOU ??

Those who, MAKE things happen.
Those who WATCH things happen.
Those who WONDER what the ... HAPPENED ???

We can make this HAPPEN way FASTER Working as a TEAM !!!

WHAT Matters is how much you CARE about KILLING CANCERS ...

This is it ... We are ALL Here ... Now ... with a Bunch of Celebrities going on TV Worldwide to Start raising $20 Million to Keep Killing Cancers.



2023 Audit considerations NASDAQ.

Cannabis Science Inc.
Share Structure 2023

Par Value: $0.001 USD
Last Price: $0.00647 USD
OTC Markets.

Common Stock:
Authorized:
5,000,000,000
Issued:
2,521,095,296

Class A Common Stock
Authorized:
100,000,000
Issued:
0

Class B Common Stock
Authorized:
1,500,000,000
Issued:
0

Preferred Stock
Authorized:
1,000,000
Issued:
1,000,000



Sign up for a FREE Assessment to JOIN the UNIVERSITY Team or any ASU/CSi-EDP Team for whatever your AREA of Expertise is … then say no more… you already know.

You already know our Extensive LIST of GROUNDBREAKING Products.

1-Million STRONG TV Coverage, HARVARD Award Success.

TAKE YOUR PICK AND BECOME A PART OF HISTORICAL CHANGE




*** APPLY for FREE in CONFIDENCE and Success.

Each Product launch WE RELEASE will include Equity Participation according to standard salaries and share bonus structures.

EVERYONE sign up to add your STRENGTHS to OUR COMBINED SUCCESS and lets MAKE THIS HAPPEN NOW !!!